Xylocaine 2% Inj, 20ml

Manufacturer FRESENIUS KABI Active Ingredient Lidocaine Injection Solution (Anesthetic)(LYE doe kane) Pronunciation LYE doe kane
It is used to numb an area before a procedure.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Local Anesthetic; Antiarrhythmic (Class IB)
đŸ§Ŧ
Pharmacologic Class
Voltage-gated sodium channel blocker
🤰
Pregnancy Category
Category B
✅
FDA Approved
Jan 1948
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Lidocaine is a medicine used to numb a specific area of your body. It works by temporarily blocking nerve signals in that area, so you don't feel pain during a procedure or for pain relief. It's often used for minor surgeries, dental work, or to relieve pain from certain conditions.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Take this medication exactly as directed, and adhere to all guidelines provided. This medication is administered via injection.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.

If you miss a dose, contact your doctor promptly to receive guidance on the appropriate course of action.
💡

Lifestyle & Tips

  • Report any unusual sensations (e.g., dizziness, ringing in ears, numbness around mouth) during or after administration.
  • Avoid activities requiring full sensation or coordination until the anesthetic effect has worn off (e.g., driving, operating machinery, eating if mouth is numb).

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly variable based on procedure, site, and patient factors. Max single dose typically 4.5 mg/kg (without epinephrine) or 7 mg/kg (with epinephrine), not to exceed 300 mg (without epinephrine) or 500 mg (with epinephrine).

Condition-Specific Dosing:

infiltration: 0.5% to 1% solution, up to 4.5 mg/kg (max 300 mg)
nerveBlock: 1% to 2% solution, up to 4.5 mg/kg (max 300 mg)
epidural: 1% to 2% solution, 10-20 mL (100-400 mg)
spinal: 0.5% to 5% solution, 50-100 mg (hyperbaric or isobaric)
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for routine use; use with extreme caution. Max 2-4 mg/kg.
Infant: Max 4-5 mg/kg (without epinephrine) or 7 mg/kg (with epinephrine).
Child: Max 4-5 mg/kg (without epinephrine) or 7 mg/kg (with epinephrine).
Adolescent: Max 4-5 mg/kg (without epinephrine) or 7 mg/kg (with epinephrine).
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment typically needed for single dose.
Moderate: No specific adjustment typically needed for single dose.
Severe: Use with caution; consider lower doses due to potential accumulation of active metabolites (MEGX, GX).
Dialysis: Lidocaine is not significantly removed by hemodialysis. Use with caution due to potential accumulation of metabolites.

Hepatic Impairment:

Mild: Use with caution; consider lower doses.
Moderate: Reduce dose by 50% or more; monitor for toxicity.
Severe: Contraindicated or significantly reduced dose (e.g., 75% reduction); monitor closely for toxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. It blocks voltage-gated sodium channels in the neuronal cell membrane, preventing depolarization and propagation of action potentials.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable, depends on site of administration and presence of vasoconstrictors (e.g., epinephrine). Systemic absorption occurs from all sites of administration.
Tmax: Variable, 5-15 minutes (epidural), 60-90 minutes (subcutaneous).
FoodEffect: Not applicable for injectable formulation.

Distribution:

Vd: 0.7-2.7 L/kg (adults); higher in neonates.
ProteinBinding: 60-80% (primarily to alpha-1-acid glycoprotein and albumin).
CnssPenetration: Yes

Elimination:

HalfLife: 1.5-2 hours (adults); prolonged in hepatic impairment, heart failure, and neonates.
Clearance: Approximately 10 mL/min/kg.
ExcretionRoute: Renal (less than 10% unchanged drug, remainder as metabolites).
Unchanged: Less than 10%
âąī¸

Pharmacodynamics

OnsetOfAction: 2-5 minutes (infiltration, nerve block); 5-15 minutes (epidural).
PeakEffect: Variable, depends on site and dose.
DurationOfAction: 30-60 minutes (without epinephrine); 60-120 minutes (with epinephrine).

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following signs or symptoms, contact your doctor or seek medical attention immediately:

Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Methemoglobinemia: Blue or gray discoloration of the lips, nails, or skin, abnormal heartbeat, seizures, severe dizziness or fainting, severe headache, excessive sleepiness, feeling tired or weak, or shortness of breath. This rare condition can be life-threatening if left untreated.
Acidosis (Too Much Acid in the Blood): Confusion, rapid breathing, rapid heartbeat, abnormal heartbeat, severe stomach pain, nausea, vomiting, excessive sleepiness, shortness of breath, or feeling extremely tired or weak.
Respiratory Problems: Trouble breathing, slow breathing, or shallow breathing.
Neurological Symptoms: Feeling lightheaded, sleepy, confused, or experiencing blurred vision.
Cardiovascular Issues: Slow heartbeat.
Nervous System Symptoms: Feeling nervous and excitable, trouble speaking, burning, numbness, or tingling sensations, restlessness, anxiety, changes in vision, ringing in the ears, dizziness or fainting, severe headache, twitching, shakiness, seizures, feeling hot or cold, metallic taste, or chest pain.
Mood Changes: Changes in mood or emotional state.

Additional Side Effects of Spinal Injection:

Sexual Dysfunction: Difficulty getting or maintaining an erection.
Motor Function: Loss of movement or control over stools and urine.
* Urinary Problems: Trouble passing urine.

Other Side Effects:

Not all side effects are severe, and many people may experience no side effects or only minor ones. However, if you notice any side effects that bother you or persist, contact your doctor for guidance. This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor.

Reporting Side Effects:

You can report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch. Your doctor can also provide medical advice and guidance on managing side effects.
🚨

Seek Immediate Medical Attention If You Experience:

  • Dizziness or lightheadedness
  • Ringing in the ears (tinnitus)
  • Numbness or tingling around the mouth
  • Blurred or double vision
  • Tremors or muscle twitching
  • Feeling anxious or restless
  • Difficulty breathing
  • Unusual drowsiness or confusion
  • Slow or irregular heartbeat
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

To ensure safe treatment, inform your doctor of the following:

Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reactions you experienced.
If you are scheduled to receive this medication via spinal injection, notify your doctor if you have:
+ Heart block
+ Severe bleeding
+ Severe infection
+ An infection at the injection site

This list is not exhaustive. It is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other treatments and health issues. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Risk of Methemoglobinemia
A severe blood disorder called methemoglobinemia has been associated with drugs like this one. Your risk may be increased if you have:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Heart problems
- Lung problems
- Are taking certain other medications
- Are an infant younger than 6 months of age
If you have a history of methemoglobinemia, notify your doctor.

Sulfite Allergy
If you are allergic to sulfites, consult with your doctor, as some products may contain sulfites.

Caution with Daily Activities
Avoid driving and engaging in activities that require alertness until the effects of this medication have worn off and you feel fully awake.

Post-Treatment Precautions
If you are discharged before the numbness has resolved, protect the treated area from injury until you have regained sensation.

Special Considerations
- If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
- If the patient is a child, use this medication with caution, as the risk of certain side effects may be higher in children.

Pregnancy and Breastfeeding
Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. You will need to discuss the potential benefits and risks to you and your baby.

Spinal Injection
If this medication is administered into the spine, it may cause temporary loss of feeling and motor function in the lower half of your body. Do not attempt to get out of bed or perform other activities until feeling and motor function have returned to normal.

Mouth and Dental Procedures
Do not eat while your mouth is numb, as you may accidentally bite your tongue.
🆘

Overdose Information

Overdose Symptoms:

  • Severe dizziness or lightheadedness
  • Seizures
  • Unconsciousness
  • Respiratory arrest (stopping breathing)
  • Cardiac arrest (heart stopping)

What to Do:

Seek immediate medical attention. Call 911 or your local emergency number. In the US, you can call Poison Control at 1-800-222-1222.

Drug Interactions

🔴

Major Interactions

  • Antiarrhythmics (e.g., amiodarone, mexiletine, procainamide, quinidine): Increased risk of cardiac depression and arrhythmias.
  • Beta-blockers (e.g., propranolol, metoprolol): Decreased hepatic metabolism of lidocaine, leading to increased lidocaine levels and toxicity.
  • Cimetidine: Decreased hepatic metabolism of lidocaine, leading to increased lidocaine levels and toxicity.
  • Other local anesthetics: Additive systemic toxicity.
🟡

Moderate Interactions

  • CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin): May increase lidocaine levels.
  • CYP3A4 inhibitors (e.g., macrolide antibiotics, azole antifungals, protease inhibitors): May increase lidocaine levels.
  • Skeletal muscle relaxants (e.g., succinylcholine): Prolonged neuromuscular blockade.
  • Phenytoin: May increase lidocaine metabolism (decreased lidocaine levels) or increase risk of cardiac depression.
đŸŸĸ

Minor Interactions

  • Cholinergic drugs: May antagonize effects.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Patient history (allergies, cardiac, hepatic, renal disease, medications)

Rationale: To identify contraindications, risk factors for toxicity, and potential drug interactions.

Timing: Prior to administration

Vital signs (heart rate, blood pressure, respiratory rate)

Rationale: To establish baseline and detect early signs of systemic toxicity.

Timing: Prior to administration

📊

Routine Monitoring

Vital signs (heart rate, blood pressure, respiratory rate)

Frequency: Every 5-15 minutes during and immediately after administration, then as clinically indicated.

Target: Within patient's normal limits; stable.

Action Threshold: Significant changes (e.g., bradycardia, hypotension, respiratory depression) warrant immediate intervention.

Neurological status (mental status, signs of CNS toxicity)

Frequency: Continuously during and immediately after administration.

Target: Alert and oriented, no signs of CNS excitation or depression.

Action Threshold: Dizziness, tinnitus, perioral numbness, tremors, seizures, somnolence.

ECG monitoring (if large doses or systemic absorption is a concern)

Frequency: Continuous during and after administration.

Target: Normal sinus rhythm, no conduction abnormalities.

Action Threshold: Bradycardia, heart block, QRS widening, ventricular arrhythmias.

đŸ‘ī¸

Symptom Monitoring

  • Lightheadedness
  • Dizziness
  • Tinnitus
  • Perioral numbness
  • Metallic taste
  • Blurred vision
  • Tremors
  • Muscle twitching
  • Seizures
  • Drowsiness
  • Confusion
  • Respiratory depression
  • Bradycardia
  • Hypotension
  • Cardiac arrest

Special Patient Groups

🤰

Pregnancy

Lidocaine is generally considered safe for use during pregnancy when clinically indicated and administered at appropriate doses. It crosses the placenta. Category B.

Trimester-Specific Risks:

First Trimester: No evidence of increased risk of congenital anomalies.
Second Trimester: Generally considered safe.
Third Trimester: Commonly used for obstetric anesthesia (e.g., epidural). Fetal bradycardia has been reported with paracervical block.
🤱

Lactation

Lidocaine is excreted into breast milk in small amounts. The amount ingested by the infant is typically very low and unlikely to cause adverse effects. Considered compatible with breastfeeding (L2).

Infant Risk: Low risk of adverse effects to the breastfed infant. Monitor for drowsiness or feeding difficulties, though unlikely.
đŸ‘ļ

Pediatric Use

Use with caution, especially in neonates and infants, due to immature hepatic metabolism and higher susceptibility to systemic toxicity. Dosing must be carefully calculated based on weight and age. Avoid formulations with preservatives (e.g., benzyl alcohol) in neonates.

👴

Geriatric Use

Use with caution. Elderly patients may be more susceptible to systemic toxicity due to decreased hepatic function, reduced protein binding, and altered body composition. Consider lower doses and monitor closely.

Clinical Information

💎

Clinical Pearls

  • Always aspirate prior to injection to avoid intravascular administration, which can lead to rapid systemic toxicity.
  • The addition of epinephrine prolongs the duration of action and reduces systemic absorption, but should be avoided in areas with end-arterial circulation (e.g., fingers, toes, nose, penis, ears) due to risk of ischemia.
  • Monitor for signs of CNS toxicity (e.g., perioral numbness, tinnitus, dizziness, tremors) as these often precede more severe cardiovascular toxicity.
  • Lipid emulsion therapy (Intralipid) is the antidote for severe local anesthetic systemic toxicity (LAST).
  • The 2% concentration (20 mg/mL) is potent; ensure correct dilution and volume for the intended procedure and patient weight.
🔄

Alternative Therapies

  • Bupivacaine (longer acting local anesthetic)
  • Ropivacaine (longer acting local anesthetic, less cardiotoxic than bupivacaine)
  • Mepivacaine (intermediate acting local anesthetic)
  • Prilocaine (intermediate acting local anesthetic)
  • Chloroprocaine (short acting local anesthetic)
💰

Cost & Coverage

Average Cost: Varies widely, typically low cost per 20ml vial
Generic Available: Yes
Insurance Coverage: Tier 1 (Generic)
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly; do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist or healthcare provider. For guidance on the best disposal method, consult your pharmacist, who may also be aware of local drug take-back programs. Some medications may come with an additional patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred.